Overview
HashiCorp, Inc., based in the United States, operates primarily within the software industry, specializing in infrastructure automation for cloud environments. The company has become pivotal in advancing cloud adoption through its suite of open-source and commercial tools that facilitate developers in provisioning, securing, connecting, and running any infrastructure for distributed application architectures. Key projects include Terraform for infrastructure as code, Vault for secrets management, Consul for service networking, and Vagrant for building and distributing development environments. HashiCorp's solutions are widely adopted across varied organizations, from startups to large enterprises, seeking scalable and efficient operational models in multi-cloud and hybrid cloud settings, thereby supporting a broad spectrum of applications in a secure, efficient infrastructure framework.
Basic Stats
The share price of Healthpeak Properties, Inc. as of March 1, 2024 is $17.10 / share. The market cap (or net worth) of Healthpeak Properties, Inc. as of September 4, 2025 is $11,883.06 MM.
The Factor Analysis chart (below right) shows a view of Healthpeak Properties, Inc. from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | 11,883.06 MM |
| EV | 21,668.59 MM |
| Shares Out. | 694.92 MM |
| Earnings Date | |
| EPS (TTM) | 0.24 |
| Dividend Yield | |
| Ex-Dividend Date | |
| Borrow Rate | |
| Short Shares Avail. | |
| Short Interest | |
| Short Float | |
| Days to Cover | |
| Risk Free Rate | 4.22 % |
| Price Change (1 yr) | |
| Volatility (1 yr) | |
| Beta | |
| Sharpe Ratio (1 yr) | |
| Sortino Ratio (1 yr) |
| PE Ratio | 72.05 |
| Price/Book | 1.38 |
| Price/TBV | 1.64 |
| Book/Market | 0.72 |
| EBIT/EV | 0.01 |
| EBIT(3yr avg)/EV | 0.02 |
| ROA | 0.01 |
| ROE | 0.02 |
| ROIC | 0.01 |
| CROIC | 0.00 |
| OCROIC | 0.07 |
| Implied Volatility | |
| Put/Call OI Ratio |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for Healthpeak Properties, Inc. is $21.70. The forecasts range from a low of $18.18 to a high of $27.30. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Healthpeak Properties, Inc.. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2022-12-14 | RBC Capital | Outperform | Sector Perform | Downgrade |
| 2022-11-21 | Evercore ISI Group | In-Line | Outperform | Upgrade |
| 2022-11-01 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-09-28 | Wolfe Research | Peer Perform | Outperform | Upgrade |
| 2022-09-09 | Barclays | Overweight | Maintains | |
| 2022-08-31 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-07-29 | Mizuho | Neutral | Maintains | |
| 2022-07-15 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-07-08 | Citigroup | Neutral | Buy | Upgrade |
| 2022-06-30 | Jefferies | Hold | Maintains | |
| 2022-06-01 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-05-20 | RBC Capital | Outperform | Maintains | |
| 2022-05-19 | B of A Securities | Buy | Neutral | Downgrade |
| 2022-04-04 | Credit Suisse | Neutral | Maintains | |
| 2022-03-07 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-02-01 | Credit Suisse | Neutral | Initiate | |
| 2021-12-20 | JP Morgan | Neutral | Overweight | Upgrade |
| 2021-12-06 | Wolfe Research | Peer Perform | Initiate | |
| 2021-11-29 | Morgan Stanley | Equal-Weight | Maintains | |
| 2021-11-18 | RBC Capital | Outperform | Maintains | |
| 2021-09-13 | Morgan Stanley | Equal-Weight | Maintains | |
| 2021-07-26 | Morgan Stanley | Equal-Weight | Maintains | |
| 2021-07-23 | Wells Fargo | Underweight | Maintains | |
| 2021-05-24 | RBC Capital | Outperform | Maintains | |
| 2021-05-20 | JP Morgan | Overweight | Neutral | Downgrade |
| 2021-05-20 | Berenberg | Hold | Buy | Upgrade |
| 2021-03-30 | B of A Securities | Neutral | Buy | Upgrade |
| 2021-03-15 | Morgan Stanley | Equal-Weight | Maintains | |
| 2020-12-14 | KeyBanc | Overweight | Sector Weight | Downgrade |
| 2020-12-10 | Wells Fargo | Equal-Weight | Underweight | Downgrade |
| 2020-10-16 | Mizuho | Buy | Neutral | Downgrade |
| 2020-09-02 | Stifel | Buy | Reiterate | |
| 2020-08-21 | Morgan Stanley | Equal-Weight | Maintains | |
| 2020-04-29 | Raymond James | Outperform | Market Perform | Downgrade |
| 2020-04-21 | Mizuho | Buy | Maintains | |
| 2020-04-21 | KeyBanc | Overweight | Maintains | |
| 2020-04-07 | Citigroup | Neutral | Maintains | |
| 2020-04-03 | JP Morgan | Overweight | Maintains | |
| 2020-03-27 | Wells Fargo | Equal-Weight | Maintains | |
| 2020-03-17 | Morgan Stanley | Equal-Weight | Maintains | |
| 2019-10-08 | JP Morgan | Neutral | Overweight | Upgrade |
| 2019-10-02 | KeyBanc | Overweight | Maintains | |
| 2019-10-02 | Barclays | Overweight | Maintains | |
| 2019-09-17 | Morgan Stanley | Equal-Weight | Maintains | |
| 2019-09-10 | JP Morgan | Neutral | Maintains | |
| 2019-09-10 | Argus Research | Hold | Buy | Upgrade |
| 2019-09-03 | Stifel Nicolaus | Buy | Maintains | |
| 2019-09-03 | Stifel | Buy | Maintains | |
| 2019-09-03 | Barclays | Overweight | Initiate | |
| 2019-08-01 | Stifel Nicolaus | Buy | Maintains | |
| 2019-07-01 | KeyBanc | Overweight | Maintains | |
| 2019-06-13 | Raymond James | Market Perform | Outperform | Upgrade |
| 2019-01-09 | BMO Capital | Market Perform | Outperform | Upgrade |
| 2018-12-20 | KeyBanc | Sector Weight | Overweight | Upgrade |
| 2018-12-10 | Scotiabank | Outperform | Initiate | |
| 2018-11-02 | RBC Capital | Sector Perform | Outperform | Upgrade |
| 2018-11-01 | Cantor Fitzgerald | Overweight | Overweight | Maintains |
| 2018-10-05 | JP Morgan | Overweight | Neutral | Downgrade |
| 2018-09-28 | Cantor Fitzgerald | Neutral | Overweight | Upgrade |
| 2018-09-17 | Bank of America | Buy | Buy | Maintains |
| 2018-09-10 | Evercore ISI Group | Underperform | In-Line | Upgrade |
| 2018-08-16 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2018-08-09 | Baird | Neutral | Neutral | Maintains |
| 2018-08-08 | Cantor Fitzgerald | Neutral | Initiate | |
| 2018-08-06 | Stifel Nicolaus | Buy | Buy | Maintains |
| 2018-07-24 | Capital One Financial | Equal-Weight | Initiate | |
| 2018-06-14 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2018-05-21 | Raymond James | Outperform | Market Perform | Downgrade |
| 2018-05-21 | Evercore ISI Group | In-Line | Underperform | Downgrade |
| 2018-03-20 | Wells Fargo | Market Perform | Market Perform | Maintains |
| 2018-03-08 | Bank of America | Neutral | Buy | Upgrade |
| 2018-02-21 | UBS | Sell | Sell | Maintains |
| 2017-12-15 | JP Morgan | Neutral | Overweight | Upgrade |
| 2017-12-14 | Morgan Stanley | Equal-Weight | Maintains | |
| 2017-12-05 | Stifel Nicolaus | Hold | Buy | Upgrade |
| 2017-11-02 | Mizuho | Neutral | Buy | Upgrade |
| 2017-10-02 | UBS | Neutral | Sell | Downgrade |
| 2017-09-25 | Morgan Stanley | Equal-Weight | Maintains | |
| 2017-09-25 | Evercore ISI Group | Underperform | In-Line | Upgrade |
| 2017-09-22 | Bank of America | Buy | Neutral | Downgrade |
| 2017-07-24 | Goldman Sachs | Buy | Neutral | Downgrade |
| 2017-06-14 | Raymond James | Underperform | Outperform | Upgrade |
| 2017-04-24 | Evercore ISI Group | In-Line | Underperform | Downgrade |
| 2017-04-11 | Mizuho | Buy | Neutral | Downgrade |
| 2017-04-03 | Bank of America | Neutral | Buy | Upgrade |
| 2017-03-27 | Evercore ISI Group | In-Line | Upgrade | |
| 2017-03-20 | Morgan Stanley | Underweight | Equal-Weight | Upgrade |
| 2017-03-10 | Baird | Neutral | Initiate | |
| 2017-01-25 | Goldman Sachs | Neutral | Buy | Upgrade |
| 2016-12-13 | BMO Capital | Underperform | Market Perform | Upgrade |
| 2016-11-21 | Mizuho | Neutral | Buy | Upgrade |
| 2016-11-04 | RBC Capital | Underperform | Sector Perform | Upgrade |
| 2016-11-02 | Stifel Nicolaus | Sell | Hold | Upgrade |
| 2016-10-04 | Bank of America | Underperform | Neutral | Upgrade |
| 2016-08-25 | BTIG Research | Neutral | Initiate | |
| 2016-08-24 | Citigroup | Neutral | Maintains | |
| 2016-08-23 | UBS | Neutral | Maintains | |
| 2016-07-26 | Raymond James | Underperform | Initiate | |
| 2016-07-08 | Goldman Sachs | Neutral | Upgrade | |
| 2016-06-22 | Morgan Stanley | Equal-Weight | Underweight | Downgrade |
| 2016-05-16 | Citigroup | Neutral | Maintains | |
| 2016-05-10 | Jefferies | Underperform | Hold | Upgrade |
| 2016-04-01 | Citigroup | Neutral | Maintains | |
| 2016-03-16 | UBS | Buy | Neutral | Downgrade |
| 2016-03-15 | JP Morgan | Neutral | Maintains | |
| 2016-03-10 | Barclays | Underweight | Maintains | |
| 2016-02-25 | Jefferies | Underperform | Maintains | |
| 2016-02-11 | Stifel Nicolaus | Hold | Sell | Downgrade |
| 2016-02-10 | UBS | Buy | Maintains | |
| 2016-01-12 | Jefferies | Underperform | Downgrade | |
| 2016-01-06 | Barclays | Equal-Weight | Underweight | Downgrade |
| 2016-01-04 | Argus | Buy | Hold | Downgrade |
| 2015-09-22 | Goldman Sachs | Neutral | Sell | Downgrade |
| 2015-09-21 | Mizuho | Neutral | Maintains | |
| 2015-09-21 | Goldman Sachs | Neutral | Sell | Downgrade |
| 2015-09-08 | Evercore ISI Group | Hold | Maintains | |
| 2015-06-12 | Mizuho | Underperform | Neutral | Upgrade |
| 2015-06-08 | Jefferies | Hold | Maintains | |
| 2015-06-08 | Argus | Buy | Maintains | |
| 2015-05-06 | RBC Capital | Underperform | Maintains | |
| 2015-05-06 | BMO Capital | Underperform | Maintains | |
| 2015-04-08 | BMO Capital | Underperform | Initiate | |
| 2015-03-31 | UBS | Neutral | Buy | Upgrade |
| 2015-02-25 | Morgan Stanley | Overweight | Equal-Weight | Downgrade |
| 2015-01-26 | Mizuho | Buy | Neutral | Downgrade |
| 2015-01-14 | Wells Fargo | Outperform | Market Perform | Downgrade |
| 2015-01-08 | Barclays | Equal-Weight | Maintains | |
| 2014-12-09 | JP Morgan | Neutral | Maintains | |
| 2014-11-13 | Morgan Stanley | Equal-Weight | Overweight | Upgrade |
| 2014-10-21 | Jefferies | Buy | Hold | Downgrade |
| 2014-10-06 | ISI Group | Neutral | Initiate | |
| 2014-08-06 | Barclays | Equal-Weight | Maintains | |
| 2014-05-07 | Citigroup | Equal-Weight | Maintains | |
| 2013-11-19 | Stifel Nicolaus | Buy | Hold | Downgrade |
| 2013-10-03 | RBC Capital | Sector Perform | Underperform | Downgrade |
| 2013-09-06 | Stifel Nicolaus | Buy | Maintains | |
| 2013-08-02 | Hilliard Lyons | Underperform | Neutral | Upgrade |
| 2013-05-20 | JP Morgan | Neutral | Maintains | |
| 2013-04-02 | Stifel Nicolaus | Buy | Maintains | |
| 2013-03-12 | Macquarie | Neutral | Outperform | Upgrade |
| 2013-03-01 | BMO Capital | Underperform | Market Perform | Upgrade |
| 2013-02-05 | Barclays | Equal-Weight | Initiate | |
| 2013-01-10 | KeyBanc | Underweight | Hold | Upgrade |
| 2012-11-16 | Jefferies | Hold | Maintains | |
| 2012-10-17 | Jefferies | Hold | Maintains | |
| 2012-08-16 | JP Morgan | Neutral | Maintains | |
| 2012-08-01 | Stifel Nicolaus | Buy | Maintains | |
| 2012-07-10 | JP Morgan | Neutral | Maintains | |
| 2023-01-03 | Jefferies | Hold | Buy | Upgrade |
| 2023-02-10 | Barclays | Overweight | Maintains | |
| 2023-02-28 | Citigroup | Buy | Maintains | |
| 2023-03-10 | Morgan Stanley | Equal-Weight | Maintains | |
| 2023-05-04 | RBC Capital | Sector Perform | Maintains | |
| 2023-03-31 | Scotiabank | Sector Outperform | Sector Perform | Downgrade |
| 2023-04-06 | Citigroup | Buy | Neutral | Downgrade |
| 2023-04-20 | Wells Fargo | Equal-Weight | Initiate | |
| 2023-04-19 | Wells Fargo | Equal-Weight | Initiate | |
| 2023-04-24 | Mizuho | Neutral | Buy | Upgrade |
| 2023-06-12 | Mizuho | Buy | Buy | Reiterate |
| 2023-06-15 | Citigroup | Neutral | Neutral | Reiterate |
| 2023-06-15 | Mizuho | Buy | Buy | Reiterate |
| 2023-07-25 | Barclays | Overweight | Overweight | Maintains |
| 2023-10-11 | Exane BNP Paribas | Underperform | Initiate | |
| 2023-10-03 | Wedbush | Neutral | Initiate | |
| 2023-10-31 | Wedbush | Neutral | Neutral | Reiterate |
| 2023-10-05 | Scotiabank | Sector Perform | Sector Perform | Maintains |
| 2023-09-07 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2024-03-04 | Scotiabank | Sector Outperform | Sector Outperform | Maintains |
| 2024-01-12 | Scotiabank | Sector Perform | Sector Outperform | Upgrade |
| 2024-01-30 | Deutsche Bank | Hold | Initiate |
